Industry

MC Innovation, CorVel, and Harvard MedTech Will Present a Unique, Immersive Experience Showcasing the Virtual Reality Experience for Treatment LAS VEGAS–(BUSINESS WIRE)–A team of workers’ compensation experts will showcase innovations in mental health treatment with a groundbreaking, experiential presentation at this year’s National Workers’ Compensation and Disability conference. Pearl Monroe, Vice President, MC Innovations, LLC; … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Writing and Enforcing SOPs for FDA-Regulated Industry: Best Practices to Withstand FDA Expectations Course” training has been added to ResearchAndMarkets.com’s offering. This course is intended for all personnel directly involved in the development of standard operating procedures including those responsible for writing validation protocols or execution activities. Beginning or seasoned operational personnel who … [Read more…]

CHICAGO–(BUSINESS WIRE)–MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a targeted therapy, immuno-oncology company focused on developing potential first-in-class oncology drugs, announced today that it will present the results of a study of the anticancer agent 6-thio-dG (THIO) in hepatocellular carcinoma (HCC) in vitro and in vivo models at the EORTC-NCI-AACR (ENA) Symposium on … [Read more…]

SEATTLE–(BUSINESS WIRE)–#EHR—Tegria, a leading healthcare consulting and technology services company, today announced it has joined the ServiceNow Partner Program to offer a healthcare-optimized ServiceNow solution that improves experiences and health outcomes for patients, creates a better work environment for clinicians and staff, heightens security and lowers costs. Tegria is accelerating digital transformation with ITSM and … [Read more…]

LOUISVILLE, Ky.–(BUSINESS WIRE)–Humana Inc. celebrates the high rankings it recently received in the 2022 Hispanic Association on Corporate Responsibility (HACR) Corporate Inclusion Index™ (CII), a research initiative that measures Hispanic inclusion in the C-suite, corporate boardroom, supplier base, mid- and entry-level employee pipeline, and philanthropic sphere. HACR has been conducting the research annually for more … [Read more…]

BROOKLYN, N.Y.–(BUSINESS WIRE)–#Dialysis—Dialyze Direct, the nation’s leading provider of home hemodialysis and physiologic dialysis services in skilled nursing facilities (SNFs), announced today that the company, together with UMC Health System (UMC) in Lubbock, Texas, an award-winning public hospital and primary teaching hospital of Texas Tech University Health Sciences Center, has committed to bringing onsite dialysis … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2022 financial results after market close on Thursday, October 27, 2022. Management will hold a conference call to review the company’s third quarter 2022 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be … [Read more…]

NAARDEN, Netherlands & WALTHAM, Mass.–(BUSINESS WIRE)–Prilenia Therapeutics B.V., a clinical stage biotechnology company focused on the urgent mission to develop novel therapeutics to slow the progression of neurodegenerative and neurodevelopmental disorders, today announced the appointment of Anne Sullivan as Chief Business Officer. In this role, Ms. Sullivan will lead all strategic collaboration activities. “As Prilenia … [Read more…]

NORTHFIELD, N.H.–(BUSINESS WIRE)–EPTAM Precision Solutions (“EPTAM” or the “Company”), a Frazier Healthcare Partners (“Frazier”) portfolio company, is pleased to announce the acquisition of Sterling Manufacturing (“Sterling”) and their wholly-owned subsidiary Albright Silicone (“Albright”). Sterling is a component manufacturer headquartered in Lancaster, MA specializing in plastic injection molding and Liquid Silicone Rubber (LSR) molding serving the … [Read more…]

MENLO PARK, Calif.–(BUSINESS WIRE)–#MOA—Meliora Therapeutics, a biotech company pioneering a machine learning-driven platform to decipher oncology drugs’ true mechanisms-of-action, announced today the close of an $11M seed financing round led by HOF Capital and ZhenFund, with participation from Obvious Ventures, Village Global, BrightEdge (the impact investment arm of the American Cancer Society), Pebblebed (fund of … [Read more…]